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Growing oocytes accumulate mRNAs and proteins that support early embryogenesis. Among the most abundant of these maternal factors are
the histones. Histone mRNA accumulation and translation are mainly restricted to S-phase in somatic cells, and the mechanism by which oocytes
produce histones is unknown. In somatic cells, replication-dependent histone synthesis requires the stem–loop binding protein (SLBP). SLBP is
expressed during S-phase, binds to the 3′-untranslated region of non-polyadenylated transcripts encoding the histones, and is required for their
stabilization and translation. SLBP is expressed in oocytes of several species, suggesting a role in histone synthesis. To test this, we generated
transgenic mice whose oocytes lack SLBP. mRNAs encoding histones H3 and H4 failed to accumulate in these oocytes. Unexpectedly, mRNAs
encoding H2A and H2B were little affected. Embryos derived from SLBP-depleted oocytes reached the 2-cell stage, but most then became
arrested. Histones H3 and H4, but not H2A or H2B, were substantially reduced in these embryos. The embryos also expressed high levels of
γH2A.X. Injection of histones into SLBP-depleted embryos rescued them from developmental arrest. Thus, SLBP is an essential component of the
mechanism by which growing oocytes of the mouse accumulate the histones that support early embryonic development.
© 2007 Elsevier Inc. All rights reserved.Keywords: SLBP; Histones; Oogenesis; Maternal control; Early embryogenesisIntroduction
Growing oocytes synthesize large quantities of mRNAs and
proteins that support early embryonic development until
transcription begins. Among the most abundant of these
maternal factors are the histones. In the frog and the fly,
enough histone to assemble the chromatin of several thousand
nuclei must be produced by the oocyte (Anderson and Lengyel,
1980; Woodland, 1980). Oocytes of sea urchin and mouse
accumulate smaller amount; nonetheless, in the mouse, where
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doi:10.1016/j.ydbio.2007.10.032late 2-cell stage, one oocyte contains as much histone mRNA as
a blastocyst (Graves et al., 1985) and its histone protein content
has been estimated to be sufficient to assemble chromatin in
about eight cells (Wassarman, 1988). In somatic cells, high
levels of histone mRNA and protein synthesis occur only during
S-phase, thus coordinating histone production with the need to
assemble newly replicated DNA into chromatin. This indicates
that oocytes, which remain arrested at late G2 of the cell cycle
throughout their growth phase, have acquired the ability to
accumulate large quantities of histones independently of DNA
replication.
The restriction of histone production to S-phase in somatic
cells is achieved primarily post-transcriptionally (reviewed by
(Jaeger et al., 2005; Marzluff, 2005; Marzluff and Duronio,
2002; Osley, 1991)). The histone mRNAs that accumulate
during S-phase are not polyadenylated. Instead, they carry a
unique 3′-untranslated region that includes a highly conserved
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During S-phase, a processing reaction cleaves the primary
histone transcripts between the stem–loop and the HDE, and the
cleaved transcripts are protected from rapid degradation,
enabling them to accumulate. Processing does not occur at
other stages of the cell cycle, so stem–loop histone mRNAs do
not accumulate. Moreover, when DNA replication is inhibited,
translation of the stem–loop histone mRNAs is arrested and the
mRNAs become degraded. These regulatory mechanisms
closely couple the accumulation and translation of stem–loop
histone mRNAs to DNA replication. In addition to replication-
dependent histone synthesis, a low level of histone synthesis
persists throughout the cell cycle. These replication-indepen-
dent histones, including the specialized histone variants H2A.Z,
H3.3, H10 and the oocyte-specific H1, are encoded by
polyadenylated mRNAs (Marzluff and Duronio, 2002).
The stem–loop binding protein (SLBP), also known as the
hairpin-binding protein, plays a central role in the metabolism
of stem–loop histone mRNAs (Martin et al., 1997; Wang et al.,
1996). SLBP binds to the histone mRNA stem–loop through a
highly conserved RNA-binding domain (Dominski et al., 2001).
Histone stem–loop mRNAs are the only mRNAs known to bind
to SLBP (Townley-Tilson et al., 2006). In the nucleus, SLBP
binds to the stem–loop of newly produced transcripts and
stabilizes a base-pairing interaction between the HDE and U7
snRNA. This enables factors associated with the U7 snRNA to
perform the processing reaction that protects transcripts from
degradation (Dominski et al., 1999, 2001, 2005; Kolev and
Steitz, 2005). SLBP then accompanies the processed mRNAs to
the cytoplasm where it bridges the 3′- and 5′-ends of the mRNA
through an interaction with eIF4G and promotes their transla-
tion (Gorgoni et al., 2005; Ling et al., 2002; Sanchez and
Marzluff, 2002; Whitfield et al., 2004). Thus, SLBP is
necessary both for the accumulation of stem–loop histone
mRNAs and for their translation. Importantly, although SLBP
mRNA is constitutively present in mammalian somatic cells, the
abundance of SLBP protein is cell cycle-regulated. It accumu-
lates when cells enter S-phase and is degraded during G2
(Whitfield et al., 2000; Zheng et al., 2003). Thus, the high rate
of histone synthesis during S-phase is due to the presence, at
this stage of the cell cycle, of SLBP.
In view of the close link between SLBP and histone
synthesis in somatic cells, it is possible that SLBP might also be
required for the synthesis by oocytes of the histones that support
early embryonic development. SLBP is present in the oocytes of
the mouse (Allard et al., 2002), frog (Wang et al., 1999) and sea
urchin (Robertson et al., 2004). As well, experimental
manipulation of the quantity of SLBP in fully grown immature
and maturing oocytes of the mouse affected the rate of
translation of histone mRNAs in the oocytes and the timing
of male pronuclear formation following fertilization (Allard et
al., 2005). However, these studies did not address the role of
SLBP in the accumulation of histone mRNAs during oogenesis
nor the role of SLBP-dependent histone synthesis in supporting
early embryonic development. To study these questions
directly, we generated transgenic mice whose oocytes lack
SLBP and examined whether these oocytes accumulatedhistone mRNAs and could develop as embryos following
fertilization.
Materials and methods
Collection and culture of oocytes and embryos
Experiments were performed using CD-1 mice (Charles River Canada;
Saint-Constant, QC). Growing oocytes were obtained 12-day old females as
described (Eppig and Telfer, 1993) in the presence of 0.025% trypsin (Sigma
Chemicals, Windsor, ON) to dissociate the oocytes from the granulosa cells.
Ovulated eggs and embryos were obtained and incubated as described (Allard et
al., 2002). Following appropriate treatments, oocytes or embryos were
transferred to 0.5-ml microtubes and stored at −80 °C until analysis.
Production of SLBP dsRNA transgenic mice
A plasmid containing the zona pellucida glycoprotein-3 (zp3) promoter (a
gift from Drs. Petr Svoboda and Richard Schultz (Svoboda et al., 2001)) was
used to produce the SLBP dsRNA construct. Primers SLBP- NheI
(CGGCTAGCCGCGACAACCTGGA) and SLBP- ClaI -I (CCATC-
GATGGTCCCATAGACAC) or SLBP-ClaI-II (CCATCGATGAGAATTTATC)
were used to amplify fragments spanning nt 539–1192 and 539–1236,
respectively, of the cDNA encoding mouse SLBP (GenBank NM009193).
The PCR-generated fragments were digested using ClaI and ligated to generate
the SLBP inverted repeat (IR). SLBP IR was then digested using NheI and
inserted into the zp3 plasmid, which had been digested using XbaI, to produce
pZP3-SLBP-IR. This plasmid contained a 654-nt inverted repeat of SLBP
cDNA separated by a 50-nt spacer.
To produce transgenic mice, pZP3-SLBP-IR was double-digested using
AasI and SspI to release the 4.3 kb transgene cassette. DNAwas isolated from a
0.7% agarose gel and purified using Geneclean (Q-BioGen, Carlsbad, CA) and
eluted using injection buffer (10 mM Tris, pH 8.0, 0.1 mM EDTA prepared
using embryo-grade water (Sigma)). The DNA was diluted to a final
concentration of 5 ng/μl in injection buffer and filtered through a 0.2 μm
Ultrafree-CL filter (Millipore Canada, Mississauga, ON). Aliquots were stored
at −80 °C until use. Fertilized eggs were collected and ∼5 pl of DNA was
injected into one pronucleus using a Leica inverted microscope with Leica
micromanipulators (Leica Canada, Montreal, QC) connected to a PLI-100 Pico-
Injector (Harvard Apparatus Canada; St. Laurent, QC). Injected embryos were
cultured for 4 days after which morula or blastocyst stage embryos were
transferred into synchronized pseudopregnant mice.
Identification of transgenic mice
Founder animals were identified by Southern analysis of tail DNA. Genomic
DNA was purified by phenol/chloroform extraction and isopropanol precipita-
tion, then resuspended in water. Following digestion using BspTI, DNA
fragments were separated in an agarose gel and transferred to a membrane
(Hybond, GE Healthcare Biosciences; Baie D'Urfe, QC, Canada). Hybridization
was performed using a 742-bp probe corresponding to the DNA sequence of
enhanced green fluorescent protein (EGFP). The probe was PCR-labeled
(primers: GCCGGTCGCCACCATGGTGAGC, GCGGCCGCTTTACTTGTA-
CAGC using digoxigenin (Roche) and detected following the manufacturer's
instructions. Transgenic lines were maintained by breeding hemizygous
transgenic males. Offspring were screened using PCR to detect the EGFP
sequence in the transgene (primers: GCACCATCTTCTTCAAGGACGAC,
TCTTTGCTCAGGGCGGACTG). PCR was performed using Taq DNA
polymerase (Invitrogen, Burlington, ON, Canada) and a program of 30 cycles
of 94 °C for 30 s, 56 °C for 30 s and 72 °C for 30 s. PCR products were
visualized on 1.5% agarose gels stained using ethidium bromide.
Fertility studies
Female transgenic mice were caged with males of proven fertility and
checked daily for the presence of a vaginal plug. Following mating, they were
housed in individual cages until they gave birth. To assess pre-implantation
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detected or the following morning. Embryos were recovered and incubated as
above.
Anti-SLBP antibodies
Two antibodies against SLBP were used. One was provided by Dr. W.F.
Marzluff (University of North Carolina) and has been previously used to identify
SLBP in mouse oocytes and preimplantation embryos by immunoblotting and
immunofluorescence (Allard et al., 2002, 2005). The second was obtained from
rabbits immunized using the same peptide sequence, affinity-purified by the
Marzluff laboratory, and recognizes the same species in immunoblots and shows
the same pattern of staining in immunofluorescence as the first antibody (data
not shown). The two antibodies were used interchangeably during the
experiments.
RNA purification, cDNA synthesis and PCR amplification
RNA was extracted from oocyte or egg pools (PicoPure, Arcturus
Biosciences Mountain View, CA) and reverse-transcribed using Murine
Moloney Leukemia Virus (Invitrogen). PCR was performed using Taq DNA
polymerase (2.5 units per reaction, Invitrogen, Burlington, ON) and one (egg) or
two (oocyte) cell-equivalents of cDNA in 50 μl final volume. Primers were
designed based on Genbank sequences (Table 1). Each PCR amplification cycle
consisted of 94 °C for 30 s, primer-specific annealing temperature (Table 1) for
30 s and 72 °C for 30 s. Optimal cycle number for amplification during the
exponential phase was determined for each gene. PCR products were analyzed
in 1.5% agarose gels stained using ethidium bromide.
Immunoblotting, immunohistochemistry and immunofluorescence
Immunoblotting was performed as previously described (Allard et al., 2002,
2005). Anti-SLBP was used at a dilution of 1:2000, anti-ERK-1 (Santa Cruz
Biotechnology; Santa Cruz, CA, sc-94) at 1:1000, and anti-tubulin (Cedarlane
Laboratories) at 1:4000, and anti-histone H3 (Cell Signaling Technology, 9715)
at 1:1000.
For immunohistochemical analyses, ovaries were collected from mice
between 5 and 20 days of age and fixed in freshly prepared 4% para-
formaldehyde in PBS for 4 h. Following dehydration and embedding in
paraffin, 5-μm sections were cut and dried onto microscope slides. After
rehydration, antigen recovery was performed by exposing the slides to 0.1%
sodium citrate at 95 °C for 20 min. Slides were then incubated in blocking
buffer (5% goat serum, 5% bovine serum albumin (Sigma) in PBST) for
30 min at room temperature, and then in affinity-purified anti-SLBP diluted
1:100 in blocking buffer overnight at 4 °C with gentle agitation. Following
washing in PBST, they were incubated in HRP-conjugated anti-rabbit
secondary antibody (diluted 1:200; Invitrogen) and YOYO-1 (diluted
1:20000; Invitrogen) for 1 h at room temperature. A tyramide-based signal
amplification kit (Invitrogen) was used to enhance the fluorescent signal, afterTable 1
Primers used for RT-PCR analysis of gene expression
Protein Gene a Accession no. Primer sequences b
SLBP Slbp NM009193 F- CAGCTGCAATGACTC
actin Actb NM007393 F- GCTGTGCTATGTTGC
c-mos Mos NM020021 F- CTCCGGAGATCCTGA
Gdf9 Gdf9 NM008110 F- TGAGATTGATGTGAC
Histone H2A Hist2h2aa2 NM013549 F- GTTTGCGCTTTCGTG
Histone H2B Hist1h2bc (common) AY158937 F- AGAAGAAGGACGGC
Histone H3 Hist1h3f (common) NM013548 F- TGGCTCGTACTAAGC
Hist2h3c2 NM054045 F- GGACTTCAAGACGG
Histone H4 Hist1h4f AY158961 F- CATAGCCATGTCTGG
Hist1h4f (common) AY158961 F- GGAGTGAAGCGCAT
a Gene used to design primer is indicated. Where the primers match most genes e
b F: 5′-primer. R: 3′-primer. Both primers are written in 5′–3′ orientation.which the slides were mounted using Mowiol and covered with glass
coverslips.
Immunofluorescence analysis was performed as previously described (Fu et
al., 2003; Mohamed et al., 2001), except that a CY3-conjugated secondary
antibody (diluted 1:400; Jackson ImmunoResearch; West Grove, PA) was used
and DNA was stained using YOYO-1 diluted 1:20000. Fluorescence was
visualized and images captured using a Zeiss LSM 510 Meta Confocal
microscope. For each experiment, control and SLBP-depleted embryos stained
with the same antibody were processed at the same time and mounted on the
same microscope slide. Image-capture parameters below saturation were
identified for each slide and images of each control and transgenic embryo
were recorded under identical conditions. Fluorescence was quantified using
ImageJ 1.36b software (National Institutes of Health, Bethesda, MD). For each
slide, the mean value obtained for control embryos was set to 1 and the value for
each control and transgenic embryo was normalized to this, enabling means and
standard errors of the mean to be calculated. To label DNA synthesized during
the first or second cell cycle, embryos were incubated in KSOM supplemented
with 100 μM bromo-deoxyuridine (BrdU) from 20 to 26 h or 30 to 46 h,
respectively, post-hCG. Embryos were processed as above, except that they
were exposed to 2N HCl for 2 h prior to blocking.
Antibodies and suppliers were as follows. Cell Signaling Technology
(Beverly, MA): H2A (2572), H4 (2592), acetyl-H2AK5 (2576), acetyl-H2BK20
(2571), acetyl-H3K9 (9671); Chemicon International (Temecula, CA): H2B
(AB1623); Upstate Biotechnology (Charlottesville, VA): γ-H2A.X (05636), H3
(06755), di-methyl-H3K9 (07212), acetyl-H4K12 (06761); GE Healthcare
Biosciences (Montreal, QC): BrdU (RPN202). All antibodies were affinity-
purified and used at a dilution of 1:1000, except anti-H2A (1:400) and anti-
SLBP (1:200).
Injection of histones
One-cell embryos were collected 14 h post-hCG as described above. They
were injected with ∼5 pl of either sterile H2O or 10 mg/ml whole histone
(Sigma) as described for DNA injection. Microinjected embryos were cultured
in KSOM in a humidified incubator at 37 °C in 5% CO2 in air. They were
examined at regular intervals to assess developmental progression or were
incubated in the presence of BrdU to assess DNA replication as described above.Results
SLBP accumulates rapidly when oocytes enter the growth
phase
SLBP is known to be present in fully grown oocytes (Allard
et al., 2002) but the timing of its accumulation during oocyte
growth has not been described. To determine this, we took
advantage of the fact that a large number of oocytesAnnealing temperature (°C)
TG R- GCAATTATCATTCCATAC 50
TCTAG R- ATCGTACTCCTGCTTGCTGA 55
AAGGA R- CAGTGTCTTTCCAGTCAGGG 58
CTCCC R- AGTAGCTTCCTCTTTCACGG 58
ATG R- GGTTATATCACAGAGACG 50
AAGAAG R- GGTCGAGCGCTTGTTGTAAT 58
AGACC R- AGGTTGGTGTCCTCAAACAG 56
ACCTG R- GCCAACTGGATGTCCTTG 54
TCGTG R- AGGGCCTTTGAGAAAGAAGC 50
CTCCGG R- CTGGCGCTTGAGCGCGTAGA 60
ncoding a particular histone subtype, these are further designated as ‘common.’
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reaching full size at about 3 weeks of age. Ovaries from mice
between 5 and 20 days of age were fixed, sectioned and stained
using an anti-SLBP antibody (Fig. 1). The specificity of the
antibody for SLBP was confirmed by the absence of staining
when the primary antibody was omitted (not shown) and in
transgenic animals whose oocytes lack SLBP (Fig. 3). SLBPwas not detectable in non-growing oocytes within primordial
follicles (Fig. 1A, arrowheads in Fig. 1B). SLBP was clearly
detected, however, in growing oocytes within primary follicles
of these ovaries (Figs. 1A, B). In most oocytes within primary
follicles, SLBP was more concentrated in the nucleus than the
cytoplasm (arrow in Fig. 1C); however, in some cases it was
predominantly cytoplasmic (arrowhead in Fig. 1C). SLBP
remained detectable in growing oocytes in secondary follicles
(Fig. 1D) and in fully-grown oocytes in antral follicles (Fig.
1E). Thus, SLBP is present throughout oocyte growth, when
these cells are accumulating histone mRNAs.
SLBP does not accumulate in oocytes expressing
double-stranded RNA targeting SLBP mRNA
To study the function of the SLBP produced during oocyte
growth, we inhibited its accumulation, using a strategy based on
generating mice that carry a transgene encoding double-
stranded (ds) RNA corresponding to the target gene under the
control of the zp3 gene promoter (Stein et al., 2003), which is
active specifically in growing oocytes (Philpott et al., 1987).
This strategy has been used to deplete several gene products
from oocytes (Fedoriw et al., 2004; Han et al., 2005; Ma et al.,
2006; Stein et al., 2003). Diagrams of SLBP mRNA, the
fragment that was used to generate the dsRNA sequence, and
the construct into which the dsRNA was inserted are shown in
Fig. 2A. Transgenic mice were generated by pronuclear
injection and male founders were used to generate transgenic
lines. Transgenic animals were obtained by mating transgenic
males to wild-type females and were identified using Southern
blotting (Fig. 2B) or PCR.
To test whether SLBP accumulated in the oocytes of
transgenic females, these animals and their wild-type littermates
were superovulated and the eggs were subjected to either RT-
PCR or immunoblotting. SLBP mRNA and protein were
substantially depleted in eggs of transgenic females (Figs. 3A,
B). We then determined at what stage of oocyte growth SLBP
became depleted. Ovaries were collected from transgenic mice
between 5 and 20 days of age, sectioned and stained using the
anti-SLBP antibody as described for the wild-type animals. The
transgenic ovaries contained many oocytes at different stages of
growth and were morphologically indistinguishable from those
of wild-type mice (Fig. 3C). Thus, there was no obvious effect
of on the dynamics of oogenesis. However, SLBP was
undetectable in oocytes at any stage of growth. These resultsFig. 1. Expression of SLBP in wild-type oocytes. Ovarian sections were stained
using YOYO-1 to label DNA (left panels) and anti-SLBP (right panels), except
in panel Awhere right panel shows overlaid images. (A) Ovary of 5-day animal
showing primordial and primary follicles. SLBP is detectable in growing
oocytes in primary follicles. Scale bar=100 μm. (B) Non-growing and growing
oocytes. SLBP is detectable in growing oocytes in primary follicles but not in
non-growing oocytes in primordial follicles (arrowheads). Bar=20 μm. (C).
Growing oocytes in primary follicles. SLBP is mainly cytoplasmic is some
oocytes (arrowhead) and mainly nuclear in others (arrow). Bar=20 μm. (D)
Growing oocyte in secondary follicle. SLBP is present throughout the
cytoplasm. Nucleus not visible in this section. Bar=20 μm. (E) Fully-grown
oocyte in antral follicle. SLBP is present throughout the cytoplasm. Nucleus not
visible in this section. Bar=50 μm.
Fig. 2. (A) Construct encoding dsRNA targeting SLBP. At the bottom is shown
the portion of the SLBP mRNA used to generate the dsRNA (long arrows) and
the location of the primers used for RT-PCR. In the middle is shown the dsRNA
construct and relevant restriction sites. At the top is shown the construct into
which the dsRNAwas inserted at the XbaI site. (B) Southern blot of transgenic
(lanes 3, 4, 6) and non-transgenic (lanes 1, 2, 5, 7) animals.
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oocytes of transgenic animals.
Embryos derived from SLBP-depleted oocytes arrest at the
2-cell stage
To test whether the SLBP in the oocyte is required for
subsequent development, we tested the fertility of the
transgenic females. Transgenic females mated with wild-type
males produced an average of 2.45±0.92 pups per litter
(6 females from 3 independent lines). In contrast, their wild-
type littermates produced an average of 14.08±0.65 pups per
litter. Thus, the failure to accumulate SLBP during oogenesis
was associated with impaired fertility. To determine the basis
of the impaired fertility, we mated the animals and flushed the
embryos from the reproductive tract at 20 h post-hCG. Similar
numbers of 1-cell embryos were recovered from wild-type
and transgenic animals (Table 2). This suggests that the lack
of SLBP did not impair oogenesis, consistent with the
apparently normal morphology of the ovary as observed in
histological sections (Fig. 3). When the embryos were placed
in culture, most (81%) derived from wild-type mothers
developed to the blastocyst stage (Table 2). In contrast, only
25% of embryos from transgenic females were able to cleave
to the 4-cell stage. Almost all embryos that reached the 4-cell
stage, however, subsequently developed to the blastocyst
stage. These results establish that the SLBP mRNA and/or
protein that accumulates during oogenesis is required for early
embryonic development.mRNAs encoding histones H3 and H4 are selectively depleted
in SLBP-deficient oocytes
We then examined whether mRNAs encoding each of the
four core histones accumulated in the oocytes and eggs of
transgenic animals. As each core histone is encoded by
numerous genes (Marzluff et al., 2002), primers were designed
as follows (see Supplementary Table S1). Histone H2A is
encoded by at least twenty genes; however, 90% of the histone
H2A mRNA in the oocyte derives from the Hist1h2aa2 gene
(Graves et al., 1985) and primers were designed to match this
gene. Histone H2B is encoded by seventeen genes. As no
individual gene contributing more than 5% of the H2B-
encoding mRNA in mouse oocytes has been identified (Graves
et al., 1985), primers that match or nearly match all genes were
designed. Histone H3 is encoded by thirteen genes that carry the
stem–loop sequence and by two genes that encode the variant
H3.3 and carry a polyadenylation signal. About 90% of the H3-
encoding mRNA in mouse oocytes is transcribed from two
genes, Hist1h3f and Hist2h3c2 (Graves et al., 1985) and two
sets of primers were designed. These primers also match the
other stem–loop type H3-encoding genes, although they match
those encoding H3.3 less well. Histone H4 is encoded by
thirteen genes. As Hist1h4f is known to be expressed in oocytes
(Allard et al., 2005; Graves et al., 1985), primers were designed
to match this gene. As well, a second set was designed that
matches or nearly matches the other H4-encoding genes.
mRNA obtained from ovulated eggs of transgenic and wild-
type females was analyzed by RT-PCR using primers targeting
the different histone subtypes and several non-histone gene
products (Fig. 4A). Both types of eggs contained similar
quantities of the non-histone mRNAs. Moreover, both con-
tained similar quantities of histone H2A and H2B mRNAs. In
contrast, histone H3 and H4 mRNAs were substantially
depleted in eggs of transgenic females as compared to those
of wild-type females. This difference was observed using two
sets of primers for each subtype. As the mRNAs that are present
in the ovulated egg accumulated during oocyte growth, we
examined expression of the histone genes in growing oocytes
(Fig. 4B). Oocytes of transgenic and wild-type females
contained similar amounts histone H2A and H2B mRNAs.
However, histone H3 mRNA was substantially depleted in
oocytes of transgenic females. In the case of histone H4, oocytes
of transgenic females produced little PCR product using primers
that matched Hist1h4f specifically, but no difference between
transgenic and wild-type oocytes was observed using the
general H4 primers. This suggests that mRNAs derived from
some histone H4-encoding genes began to accumulate during
oocyte growth, although they apparently did not persist.
Immunoblotting revealed that histone H3 was reduced by
slightly more than half in ovulated eggs of transgenic as
compared to wild-type females; we have not yet found
antibodies with sufficient sensitivity to measure the other
histones (data not shown). These results indicate that oocytes
lacking SLBP are unable to normally accumulate mRNAs
encoding histones H3 and H4, but those encoding histones H2A
and H2B are much less affected.
Fig. 3. Expression of SLBP in transgenic animals. (A) Ovulated eggs from wild-type (wt) or transgenic (tg) animals were analyzed using RT-PCR to detect mRNA
encoding actin (Actb) and SLBP (Slbp). SlbpmRNA is depleted in transgenic oocytes. (B) Ovulated eggs from wild-type (wt) or transgenic (tg) animals were subjected
to immunoblotting using the indicated antibodies. Each lane contains 25 eggs collected from an individual mouse. SLBP is depleted in eggs of transgenic mice. (C)
Ovarian sections from transgenic mice were stained using YOYO-1 (left panels) and anti-SLBP (right panels). Images were collected using parameters identical to
those in Fig. 1. (a) Ovary of 5-day animal showing primordial and primary follicles. (b) Higher magnification view of a 5-day ovary. (c) Ovary of 10-day animal
showing oocyte in secondary follicle. Inset on left panel was obtained at higher-power to reveal the nucleus. (d) Ovary of a 20-day animal showing oocyte in antral
follicle. SLBP is not detectable in oocytes at any stage of growth.
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the second round of DNA replication and lack histones H3 and
H4
The results above suggested that the arrest of SLBP-depleted
embryos at the 2-cell stage might be due to insufficient histones
H3 and H4. We therefore examined the cell-cycle progression
and histone content of these embryos. Embryos were incubated
in the presence of BrdU during either the first or second roundTable 2
Preimplantation development in vitro of embryos from transgenic and non-
transgenic females
Genotype No. of
mice
No. of
eggs
Number (%) that reached indicated stage a
2-cell 4-cell morula/blastocyst
Non-transgenic 7 190 188 (99) 166 (87) 153 (81)
Transgenic b 7 148 133 (90) c 37 (25) c 32 (22) c
a Embryos were flushed from the oviduct at 20 h post-hCG and cultured in
vitro for 4 days.
b Embryos from three independent lines were analyzed.
c Differs significantly from non-transgenic (Chi-square, pb0.01).of embryonic DNA replication. Following fixation and staining
with an anti-BrdU antibody, images were recorded using a
confocal microscope and the fluorescent signal was quantified.
BrdU incorporation during the 1-cell stage was slightly reduced
in SLBP-depleted embryos as compared with wild-type
embryos (Figs. 5A, B). It was substantially reduced, however,
during the 2-cell stage. Thus, the second round of DNA
replication was severely impaired in the SLBP-depleted
embryos.
We then examined the abundance of each of the four core
histones. The pool of histones in the mouse egg is sufficient to
assemble about eight nuclei (Wassarman, 1988). Thus, 2-cell
embryos contain both histone incorporated into chromatin and
non-incorporated histone in the nucleoplasm. Wild-type and
SLBP-depleted embryos were stained using antibodies recog-
nizing each core histone and the signal was quantified as above.
First, we used antibodies directed against unmodified forms of
the histones. This immunofluorescent analysis indicated that
SLBP-depleted embryos contained much less histones H3 and
H4 than wild-type embryos (Figs. 6A, B). In contrast, histones
H2A and H2B were not detectably or only slightly reduced in
Fig. 4. Expression of histone and non-histone genes in oocytes of wild-type (wt) and transgenic (tg) animals. Ovulated eggs (A) and growing oocytes (B) were
analyzed using RT-PCR to detect the indicated mRNAs. The experiments were performed twice using independent pools of eggs. Where primers match only one or a
few genes encoding a histone subtype, the relevant gene is identified. Where the primers match most genes encoding a subtype, they are identified as ‘common.’ See
Supplementary Table S1 for further details. mRNAs encoding histones H3 and H4 are depleted in ovulated eggs of transgenic females, but little difference is evident
for H2A and H2B. mRNA encoding H3 is depleted in growing oocytes, whereas some mRNA encoding H4 is detectable at this stage.
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the results of the mRNA analysis and indicated that the total
amount of histone H3 and H4 was reduced in SLBP-depleted
embryos, whereas the total amount of histones H2A and H2B in
these embryos was similar to wild-type.
To examine histones within chromatin specifically, we used
antibodies that recognize modifications that may be imposed on
histones during or following their assembly into chromatin
(Nightingale et al., 2006; Sobel et al., 1995). First, we used
antibodies recognizing acetylated forms of each of the core
histones. Acetylated histones H3 and H4 are associated with
transcriptionally active chromatin, which is replicated during
early S-phase (Belyaev et al., 1996; Gilbert, 2002). Although 1-
and early 2-cell mammalian embryos are only weakly
transcriptionally active (reviewed by (Kanka, 2003; Schultz,
2002)), their pattern of DNA replication implies the existence of
transcriptionally competent and incompetent domains (Ferreira
and Carmo-Fonseca, 1997). Thus, antibodies recognizing
acetylated histones may preferentially label early-replicating
chromatin. As a complementary approach, we used an antibody
recognizing K9-methylated histone H3, a modification asso-
ciated with transcriptionally inactive late-replicating chromatin
(Mcnairn and Gilbert, 2003; Wallace and Orr-Weaver, 2005).
Acetylated forms of all four histones were significantly
reduced in the SLBP-depleted embryos as compared with
controls (Fig. 6C). The degree of reduction was similar for all
four antibodies, which is consistent with the equimolar
representation of histones in chromatin. However, K9-methy-lated histone H3 was reduced to a much greater degree in SLBP-
depleted embryos. These results suggest that, as compared with
controls, the chromatin of the SLBP-depleted embryos
contained moderately less acetylated histone and substantially
less K9-methylated histone H3. These results are consistent
with a developmental arrest during S-phase. To further test
whether developmental arrest occurred during S-phase, we
stained 2-cell embryos using an antibody against phosphory-
lated (γ-) H2A.X, which is present at sites of double-stranded
DNA breaks (Wurtele and Verreault, 2006) and might be
expected to accumulate if DNA replication was impaired.
Consistent with this prediction, SLBP-depleted embryos
displayed a considerably higher level of γ-H2A.X than wild-
type embryos (Fig. 6D). Taken together, these results strongly
suggest that SLBP-depleted embryos fail to complete the
second round of DNA replication and that this is mainly due to
an insufficient supply of histones H3 and H4.
Exogenous histones rescue development of SLBP-depleted
embryos
The results described above suggested that the develop-
mental arrest of SLBP-depleted embryos was due to a lack of
histones. To test this hypothesis, we examined whether
development of the SLBP-depleted embryos could be rescued
by exogenous histones. SLBP-depleted one-cell embryos were
injected with 50 pg of mixed histones or with water. To
determine whether the defect in the second round of DNA
Fig. 5. (A) DNA replication in embryos derived from wild-type (wt) or
transgenic (tg) eggs. Embryos were incubated in the presence of BrdU, then
stained using anti-BrdU. Images are of 2-cell embryos. Staining is much weaker
in embryos derived from tg eggs. Bar=25 μm. (B) Quantification of images
from wild-type (white bars) and transgenic (black bars) embryos. Images were
recorded using a confocal microscope and analyzed using ImageJ. Female (F)
and male (M) pronuclei were analyzed separately in the 1-cell embryos. Each
bar shows the mean of at least 15 cells. The difference between the wild-type and
transgenic groups is significant in all three groups (t-test, pb0.05).
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presence of BrdU during the second round of DNA replication
and analyzed as above. BrdU incorporation was significantly
elevated in histone-injected embryos as compared with controls
(Fig. 7A). Thus, supplying exogenous histones enabled SLBP-
depleted embryos to continue the second round of DNA
replication. We then tested whether injection of histones
enabled embryos to develop beyond the 2-cell stage. Injected
embryos were incubated for 4 days and development was
assessed at regular intervals. Most (60%) of the histone-injected
embryos reached the 4-cell stage and the majority of these
subsequently became blastocysts (Fig. 7B). In contrast, only
about one-quarter of the control embryos progressed beyond the
2-cell stage. This frequency of development is the same as
observed in non-injected SLBP-deficient embryos (see Table 2).
We conclude that the failure of SLBP-depleted embryos to
develop beyond the 2-cell stage is due to an insufficient supply
of histones.
Discussion
Growing oocytes accumulate large quantities of histone
mRNAs and proteins that are required for chromatin assembly
in early embryos until transcription begins. We have studied the
role of SLBP in this process. We report that SLBP begins to
accumulate when mouse oocytes enter the growth phase and
remains present throughout growth. Oocytes that lack SLBP fail
to accumulate mRNAs encoding histones H3 and H4. Incontrast, accumulation of mRNAs encoding H2A and H2B is
little affected. Embryos derived from SLBP-depleted oocytes
showmarkedly impaired DNA replication at the 2-cell stage and
contain less histones H3 and H4 than normal embryos, and most
become developmentally arrested at this stage. Both the DNA
replication defect and the developmental arrest of SLBP-
deficient embryos are rescued by injection of histones. These
results establish that SLBP is an essential component of the
mechanism by which growing oocytes of the mouse accumulate
the histones that support early embryogenesis.
Histones H3 and H4 are encoded by thirteen and twelve
genes, respectively. If our methods measured expression from
only a subset of the encoding genes, then the reduced quantities
that we observed in the SLBP-depleted oocytes and embryos
might not reflect the actual quantity of each subtype that is
present in the cells. This is unlikely to be the case. Regarding
histone H3, the primers selected match perfectly the two genes
that produce ∼90% of the mRNA in the oocyte, as well as the
nine other stem–loop bearing genes. These genes encode two
forms of histone H3 that differ at only one amino acid position
and would likely each be recognized by the antibody. We cannot
entirely exclude that histone H3.3, which is expressed in
oocytes (Torres-Padilla et al., 2006; Van Der Heijden et al.,
2005), was not recognized by our primers or antibodies.
However, H3.3 differs at only five and four amino acids from
H3.1 and H3.2, respectively, and contains the K9 that is
recognized by the anti-methyl-K9-H3 antibody. Regarding
histone H4, the primers used for PCR match ten of the twelve
genes exactly, and the proteins encoded by all twelve are
identical and thus would be recognized by the antibody. Thus,
there are unlikely to be forms of histone H3 or H4 that are
present in significant quantities in the oocyte or early embryo
but are undetected by our methods. We conclude that SLBP is
required for the accumulation of histones H3 and H4 in mouse
oocytes.
In contrast to its essential role with respect to histones H3
and H4, SLBP is not required for the accumulation of histones
H2A and H2B in oocytes. The major H2A-encoding gene
expressed in oocytes (Hist1h2aa2) and the known H2B-
encoding genes all bear a stem–loop sequence. Thus, the
SLBP-independent accumulation of H2A and H2B and their
encoding mRNAs was unexpected. It has previously been
observed that Hist1h2aa2 gives rise to a small quantity of
polyadenylated mRNA in mouse spermatids (Moss et al., 1994)
and in tissue culture cells (Levine et al., 1987), and a possible
polyadenylation signal lying 3′ to the stem–loop and U7 RNA-
binding sites has been identified (Moss et al., 1994). Spermatids
also transcribe a polyadenylated mRNA from the Hist1h2bp
gene (Moss et al., 1989). Moreover, in Drosophila embryos
carrying mutant alleles of dSLBP, the histone genes that
normally generate stem–loop mRNAs now generate polyade-
nylated mRNAs in somatic cells, although these are not found in
the oocytes (Lanzotti et al., 2002; Sullivan et al., 2001). These
results suggest that, in the absence of SLBP, transcriptional
elongation at histone genes continues until a polyadenylation
signal is encountered. Studies using HeLa tissue-culture cells,
however, are not entirely consistent with this explanation.
Fig. 6. Expression of histones in 2-cell embryos derived from wild-type (wt, white bars) and transgenic (tg, black bars) eggs. (A) Representative images of embryos
stained using antibodies against the indicated histones. Embryos derived from transgenic eggs show reduced H3 and H4 staining. Bar=25 μm. (B, C) Quantification of
images obtained using antibodies recognizing unmodified histones (B) or specific histone modifications (C). Each bar shows the mean of at least 18 cells. In all groups
except H2A, the difference between the wild-type and transgenic groups is significant (t-test, pb0.05). (D) Expression of γ-H2A.X. Embryos were stained using
propidium iodide to label the DNA (left) and with anti-γ-H2A.X (right). Embryos derived from transgenic eggs showmuch more intense γ-H2A.X staining. The small
stained structure in each panel is the second polar body. Twenty-five embryos from each group were examined; all showed the same pattern of staining. Bar=25 μm.
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(2007) observed polyadenylated mRNA derived from the
HIST2H2AA gene; however, most of the HIST2H2AA mRNA
was not polyadenylated, suggesting that it had been processed
normally despite the absence of SLBP. On the other hand,
another study reported a reduction in the quantities of mRNAs
encoding all four core histones (Zhao et al., 2004). Thus, therelative amounts of polyadenylated and non-polyadenylated
mRNAs encoding histones H2A and H2B in SLBP-depleted
oocytes needs to be determined.
Following fertilization, SLBP-depleted eggs began embryo-
nic development but most became arrested at the 2-cell stage.
The ability of the fertilized eggs to assemble the male
pronucleus and undergo the first round of DNA replication
Fig. 7. Rescue of DNA replication and embryonic development by injected
histone. (A) One-cell embryos derived from transgenic eggs were injected with
water (white bars) or with 50 pg of histone (black bars). At the 2-cell stage, they
were incubated in the presence of BrdU and then stained using anti-BrdU.
Fluorescent signals were recorded and quantified. Each bar represents the mean
of at least 43 cells. BrdU incorporation is significantly higher in the histone-
injected embryos (t-test, pb0.05). (B) Embryos injected as in panel A were
examined at regular intervals to assess developmental progression. The number
reaching each of the indicated stages is shown. The experiment was performed 6
times with a total of 95 embryos in each group. At all stages, the difference
between the two groups is significant (χ2, pb0.05).
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support these events. Several factors may contribute to this
limited histone production. First, as the dsRNA strategy may
not inactivate all copies of its target mRNA, it is reasonable to
suppose that a small amount of SLBP is present in the oocytes
of transgenic females. Second, it is possible the mRNAs
encoding histones H3 and H4 can be processed and translated,
albeit inefficiently, in oocytes lacking SLBP. Third, histone
H3.3, which is encoded by a polyadenylated mRNA, may
provide a small quantity of this subtype. Nevertheless, most
embryos failed to complete the second round of DNA
replication and became developmentally arrested. Both the
DNA replication defect and developmental arrest were rescued
by injected histone, indicating that they were due to a lack of
histones. In tissue-culture cells, insufficient histones trigger
arrest of DNA replication, DNA damage and activation of the S-
phase checkpoint (Nelson et al., 2002; Ye et al., 2003). Our
observation that SLBP-depleted embryos contained high levels
of γ-H2A.X suggest that a similar process occurs in these cells.
Taken together, these results suggest that the developmental
arrest of the SLBP-depleted embryos may be due to activation
of an S-phase checkpoint mechanism.Some embryos derived from SLBP-depleted eggs were
able to reach the 4-cell stage. These may have failed to
activate the S-phase checkpoint or may have contained
sufficient histone to complete the second S-phase. Interest-
ingly, most of these embryos subsequently developed to the
blastocyst stage. This suggests that the SLBP produced in the
oocyte is required only to support development to about the 4-
cell stage. As the major transcriptional activation occurs at the
late 2-cell stage in mice, the embryonic genes encoding SLBP
and the histones presumably are transcribed beyond this point.
Although the stability of the dsRNA targeting SLBP is
unknown, expression from the zp3 promoter stops before
oocyte meiotic maturation (Philpott et al., 1987). Thus, SLBP
embryos that reach the 4-cell stage may subsequently be able
to produce normal quantities of SLBP and histones, which in
turn support continued cycles of DNA replication and
chromatin assembly. In support of this idea, 1-cell embryos
injected with about 50 pg of histone, an amount sufficient to
package chromatin in only about 8 cells, could develop to the
blastocyst stage, strongly suggesting that the injected embryos
synthesized histones.
The role of SLBP in the accumulation of histones in oocytes
has previously been experimentally studied in Drosophila,
using mutants that carry mutant alleles of dSLBP (Lanzotti et
al., 2002; Sullivan et al., 2001). Two key differences are
apparent as compared with our studies using the mouse. First,
mRNAs encoding all four histones are reduced in the oocytes of
the mutant flies, whereas we observed a selective effect on
histones H3 and H4. This may reflect the different mechanisms
by which the oocytes of the two species accumulate histones. In
the fly, the histone mRNAs that accumulate in the oocyte are
synthesized by the nurse cells (Ambrosio and Schedl, 1985;
Ruddell and Jacobs-Lorena, 1985). These undergo several
rounds of endoreduplication prior to synthesizing the oocyte-
bound histone mRNAs (Lilly and Duronio, 2005). Low levels
of SLBP in the mutant animals would likely impair the
endoreduplication cycles, which in turn might impair the ability
of the nurse cells to support a high rate of histone gene
transcription. Thus, the reduced quantity of histone mRNAs in
oocytes of flies carrying hypomorphic dSLBP alleles may
reflect a function for this gene in the nurse cells, a view
supported by the observation that SLBP has not been detected in
oocytes (Lanzotti et al., 2002). In contrast, in the mouse, our
experiments identified a role for SLBP that is expressed in
oocytes and independently of DNA replication.
Second, unlike the case in the mouse, Drosophila embryos
derived from females carrying mutant dSLBP alleles do not
become arrested during S-phase. Instead, they undergo multiple
rounds of DNA replication and chromatin assembly, ultimately
becoming arrested owing to defects in chromosome condensa-
tion and organization on the mitotic spindle (Lanzotti et al.,
2002; Sullivan et al., 2001). Similar chromosomal defects occur
in C. elegans embryos that lack SLBP (Kodama et al., 2002;
Pettitt et al., 2002). As discussed above, the developmental
arrest of SLBP-depleted mouse embryos is likely due to
activation of the S-phase checkpoint. In flies, however, it has
been suggested that an S-phase checkpoint may not become
357D.R. Arnold et al. / Developmental Biology 313 (2008) 347–358functional until cycle 10 of embryogenesis (Crest et al., 2007).
Thus, it is possible that the early rounds of DNA replication and
chromatin assembly are impaired in Drosophila embryos, as in
the mouse, but this does not directly trigger developmental
arrest.
SLBP is also expressed in the oocytes of frogs (Sanchez and
Marzluff, 2004; Wang et al., 1999) and sea urchins (Robertson
et al., 2004) and is likely required for the accumulation of
maternal histones as it is in the mouse. In somatic cells,
although SLBP is likely required for the high rate of replication-
coupled histone synthesis (Zhao et al., 2004; Narita et al., 2007),
it is not expressed outside of S-phase (Whitfield et al., 2000;
Zheng et al., 2003) and hence plays no role in histone synthesis
in non-replicating cells. Thus, it may be questioned why
accumulation of histones in non-replicating oocytes requires
SLBP. One possibility is that SLBP-independent histone
synthesis may occur in oocytes, but the rate is too low to
enable sufficient accumulation of the proteins. This is consistent
with the fact that somatic cells synthesize histones at a far higher
rate during S-phase than at other stages of the cell cycle. On the
other hand, oocyte growth is a slow process – requiring about 3
weeks in the mouse – and it cannot be assumed that this period
is too brief to permit sufficient accumulation of histones.
Alternatively, it may be that for certain histone subtypes none of
the encoding genes can give rise polyadenylated mRNAs, so
SLBP is needed to support production of these subtypes.
Finally, even where genes that can produce a polyadenylated
transcript are known, such as those encoding histone H3.3,
perhaps the differences in amino acid sequence of the variant
mean that it cannot be used to assemble normal chromatin in
early embryos (Henikoff and Ahmad, 2005). In any case, the
activity of SLBP in growing oocytes implies that these cells,
which are at late G2 of the cell cycle, have evolved mechanisms
that enable SLBP to accumulate and function in a replication-
independent manner.
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